Cargando…
Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa
Aims. To measure blood and tissue concentrations of the H1-receptor antagonist, bepotastine besilate (BB). Methods. Participants included 14 men and six women, whose age ranged from 13 to 76 years, with chronic rhinosinusitis, who underwent endoscopic sinus surgery at our university hospital. Among...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809338/ https://www.ncbi.nlm.nih.gov/pubmed/20130774 http://dx.doi.org/10.1155/2009/495186 |
_version_ | 1782176616972025856 |
---|---|
author | Takasaki, Kenji Enatsu, Kaori Kumagami, Hidetaka Takahashi, Haruo |
author_facet | Takasaki, Kenji Enatsu, Kaori Kumagami, Hidetaka Takahashi, Haruo |
author_sort | Takasaki, Kenji |
collection | PubMed |
description | Aims. To measure blood and tissue concentrations of the H1-receptor antagonist, bepotastine besilate (BB). Methods. Participants included 14 men and six women, whose age ranged from 13 to 76 years, with chronic rhinosinusitis, who underwent endoscopic sinus surgery at our university hospital. Among them, 10 participants had allergic rhinitis (AR) (Group I), and others did not have AR (Group II). Nasal mucosa and blood were collected 55 to 130 minutes after oral administration of BB 10 mg. Concentrations of the agent in the serum and nasal mucosa were measured by high-performance liquid chromatography. Results. Concentrations of BB of the serum in Group I and II were 98 ± 32 ng/mL and 112 ± 39 ng/mL. Those of the nasal mucosa tissue in Groups I and II were 101 ± 36 ng/g and 132 ± 44 ng/g. There was no significant difference in the values of concentration of BB between the serum and the nasal mucosa in either Group I or II (P = .757 and P = .2662, resp., Paired t-test). Conclusion. This preliminary study is considered the first report on the concentration of H1-receptor antagonists in nasal mucosa. The prompt absorption and transition to the nasal mucosa of BB seems to have an effect on allergic rhinitis. |
format | Text |
id | pubmed-2809338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-28093382010-02-03 Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa Takasaki, Kenji Enatsu, Kaori Kumagami, Hidetaka Takahashi, Haruo Int J Otolaryngol Clinical Study Aims. To measure blood and tissue concentrations of the H1-receptor antagonist, bepotastine besilate (BB). Methods. Participants included 14 men and six women, whose age ranged from 13 to 76 years, with chronic rhinosinusitis, who underwent endoscopic sinus surgery at our university hospital. Among them, 10 participants had allergic rhinitis (AR) (Group I), and others did not have AR (Group II). Nasal mucosa and blood were collected 55 to 130 minutes after oral administration of BB 10 mg. Concentrations of the agent in the serum and nasal mucosa were measured by high-performance liquid chromatography. Results. Concentrations of BB of the serum in Group I and II were 98 ± 32 ng/mL and 112 ± 39 ng/mL. Those of the nasal mucosa tissue in Groups I and II were 101 ± 36 ng/g and 132 ± 44 ng/g. There was no significant difference in the values of concentration of BB between the serum and the nasal mucosa in either Group I or II (P = .757 and P = .2662, resp., Paired t-test). Conclusion. This preliminary study is considered the first report on the concentration of H1-receptor antagonists in nasal mucosa. The prompt absorption and transition to the nasal mucosa of BB seems to have an effect on allergic rhinitis. Hindawi Publishing Corporation 2009 2009-11-25 /pmc/articles/PMC2809338/ /pubmed/20130774 http://dx.doi.org/10.1155/2009/495186 Text en Copyright © 2009 Kenji Takasaki et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Takasaki, Kenji Enatsu, Kaori Kumagami, Hidetaka Takahashi, Haruo Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa |
title | Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa |
title_full | Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa |
title_fullStr | Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa |
title_full_unstemmed | Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa |
title_short | Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa |
title_sort | concentrations of h1-receptor antagonist in the human nasal mucosa |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809338/ https://www.ncbi.nlm.nih.gov/pubmed/20130774 http://dx.doi.org/10.1155/2009/495186 |
work_keys_str_mv | AT takasakikenji concentrationsofh1receptorantagonistinthehumannasalmucosa AT enatsukaori concentrationsofh1receptorantagonistinthehumannasalmucosa AT kumagamihidetaka concentrationsofh1receptorantagonistinthehumannasalmucosa AT takahashiharuo concentrationsofh1receptorantagonistinthehumannasalmucosa |